Wintin Tablet is a combination pharmaceutical formulation containing Ginkgo Biloba (60 mg), Piracetam (800 mg), and Vinpocetine (5 mg), designed to enhance cognitive function and support cerebral circulation. Ginkgo Biloba, a well-known herbal extract, exhibits antioxidant properties and promotes vasodilation, thereby improving blood flow to the brain. Piracetam, a nootropic agent, modulates neurotransmission and enhances neuronal membrane fluidity, contributing to improved memory, learning, and overall cognitive performance. Vinpocetine acts as a cerebral vasodilator and neuroprotective agent by increasing cerebral blood flow and oxygen utilization, which may aid in the management of cognitive decline and neurodegenerative conditions. The synergistic effect of these active ingredients supports neurovascular health, potentially benefiting patients with cognitive impairments related to aging, cerebrovascular insufficiency, or neurodegenerative disorders. Wintin Tablet is indicated as an adjunct therapy for cognitive dysfunction, memory impairment, and conditions associated with reduced cerebral perfusion. It should be used under medical supervision, with caution advised in patients with bleeding disorders or those on anticoagulant therapy due to the antiplatelet effects of Ginkgo Biloba. Adverse effects are generally mild but may include gastrointestinal discomfort, headache, or dizziness. Proper dosage and duration of therapy should be determined by a healthcare professional based on individual patient needs.